HIT Consultant July 30, 2025
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites, and sponsors, particularly in neurological disease trials, where phase III trials cost up to $370 million, last 7.9 years, and face a 95% failure rate among drug candidates 1,2,3. Moreover, traditional site-based data collection methods do not capture the complete picture of how patients are affected by their disease and how they respond to treatment. To expand our understanding of disease processes and therapeutic effects, clinical trial sponsors are embracing sensor technology, which provides an opportunity to not only enhance clinical evidence, we can reduce the time and costs of clinical research while...
Today's Sponsors
Today's Sponsor